title: [Anti-arrhythmia properties of the novel combined preparation based on sufan and possible mechanism of their realization].
authors.forename: A I
authors.initials: AI
authors.lastname: Khankoeva
authors.forename: A S
authors.initials: AS
authors.lastname: Dukhanin
authors.forename: N B
authors.initials: NB
authors.lastname: Leonidov
authors.forename: P A
authors.initials: PA
authors.lastname: Galenko-Iaroshevskiĭ
authors.forename: D S
authors.initials: DS
authors.lastname: Galygo
mesh_terms: D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D001157:Arterial Occlusive Diseases / Q000150:complications / Q000503:physiopathology; D001565:Benzoates / Q000009:adverse effects / Q000494:pharmacology*; D002118:Calcium / Q000378:metabolism; D002415:Cats; D015687:Cell Hypoxia; D004357:Drug Synergism; D066298:In Vitro Techniques; D015428:Myocardial Reperfusion Injury / Q000150:complications / Q000503:physiopathology / Q000517:prevention & control; D009206:Myocardium / Q000166:cytology / Q000378:metabolism; D026941:Sodium Channel Blockers; D013386:Succinates / Q000008:administration & dosage / Q000494:pharmacology*; D014364:Tryptophan / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D014693:Ventricular Fibrillation / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control
chemical_list: D000889:Anti-Arrhythmia Agents; D001565:Benzoates; D026941:Sodium Channel Blockers; D013386:Succinates; C111552:dimethylaminoethyl p-butylaminobenzoate; C107888:sufan; D014364:Tryptophan; D002118:Calcium
vernacular_title: Antiaritmicheskie svoĭstva novogo kombinirovannogo preparata na osnove sufana i vozmozhnyĭ mekhanizm ikh realizatsii.